| 1. | | No longer recruiting | "Clinical Trials to Enhance Elders' Oral Health" ("TEETH")
Conditions: Tooth Loss; Periodontal Disease; Tooth decay |
| 2. | | Recruiting | "REDUCE" - A Clinical Research Study To Reduce The Incidence Of Prostate Cancer In Men Who Are At Increased Risk
Condition: Prostate Cancer |
| 3. | | Completed | (Ro 24-2027) A Randomized, Double-Blind, Comparative Study of Dideoxycytidine (ddC) versus Zidovudine (AZT) in Patients With AIDS or Advanced ARC
Condition: HIV Infections |
| 4. | | No longer recruiting | A 1-Year Study of an Investigational Drug in Obese Patients
Condition: Obesity |
| 5. | | No longer recruiting | 12 Week Study of Anti-Viral Effect of Oral UT-231B in Non-cirrhotic Hepatitis C Patients who have Failed Interferon-based Therapy.
Condition: Hepatitis C |
| 6. | | Completed | 12 week,comparing safety of HMR1964 & insulin aspart used in continuous subcutaneous infusion in type 1 diabetes.
Condition: Diabetes, type I |
| 7. | | No longer recruiting | A 12-week, multicenter, safety and dose-ranging study of 3 oral doses of TCH346 in patients with Amyotrophic Lateral Sclerosis
Condition: Amyotrophic Lateral Sclerosis |
| 8. | | Recruiting | A 14-day study of Racivir when used in combination in HIV-Infected Males
Condition: HIV Infections |
| 9. | | Recruiting | 2 doses of an Approved Drug Being Studied for a New Indication for the Prevention of Postoperative Nausea and Vomiting
Condition: Postoperative Nausea and Vomiting |
| 10. | | Recruiting | 2 Doses of an Approved Drug Being Studied for a New Indication for the Prevention of Postoperative Nausea and Vomiting
Condition: Postoperative Nausea and Vomiting |
| 11. | | No longer recruiting | A 2-Year Study of an Investigational Drug in Obese Patients
Condition: Obesity |
| 12. | | Recruiting | A 20-week study of a new treatment for men with Benign Prostatic Hyperplasia (BPH).
Condition: Prostatic Hyperplasia |
| 13. | | Recruiting | A 24 Week Study of Daily Oral Investigational Drug vs Placebo in Patients with Asthma
Condition: Asthma |
| 14. | | Completed | A 28-Day Study of Diclazuril in the Treatment of Cryptosporidiosis in Patients with AIDS
Conditions: Cryptosporidiosis; HIV Infections |
| 15. | | No longer recruiting | 3 Different Dose Levels of CCI-779 in Subjects with Active Rheumatoid Arthritis on Concomitant Methotrexate Therapy
Condition: Rheumatoid Arthritis |
| 16. | | Recruiting | 3 Fixed Dosages of Extended Release OROS Paliperidone and Olanzapine in the Treatment of Subjects with Schizophrenia
Condition: Schizophrenia |
| 17. | | No longer recruiting | 3-Aminopyridine-2-carboxaldehyde Thiosemicarbazone in Treating Patients With Solid Tumors
Condition: unspecified adult solid tumor, protocol specific |
| 18. | | No longer recruiting | 3-AP and Cytarabine in Treating Patients With Hematologic Cancer
Conditions: acute leukemia; atypical chronic myeloid leukemia; chronic leukemia; myelodysplastic and myeloproliferative disease |
| 19. | | Recruiting | 3-AP and Gemcitabine in Treating Patients With Metastatic Non-Small Cell Lung Cancer
Conditions: recurrent non-small cell lung cancer; stage IV non-small cell lung cancer |
| 20. | | Suspended | 3-AP and Gemcitabine in Treating Patients With Unresectable or Metastatic Pancreatic Cancer
Conditions: stage II pancreatic cancer; stage III pancreatic cancer; stage IVA pancreatic cancer; stage IVB pancreatic cancer; recurrent pancreatic cancer |
| 21. | | No longer recruiting | 3-AP in Treating Patients With Advanced Cancer
Condition: unspecified adult solid tumor, protocol specific |
| 22. | | No longer recruiting | 3-AP in Treating Patients With Advanced Prostate Cancer
Conditions: recurrent prostate cancer; stage IV prostate cancer |
| 23. | | No longer recruiting | 3-AP Plus Cisplatin and Paclitaxel in Treating Patients With Advanced or Metastatic Cancer
Condition: unspecified adult solid tumor, protocol specific |
| 24. | | Completed | 3TC (Lamivudine; GR109714X) Open-Label Program
Condition: HIV Infections |
| 25. | | Recruiting | 48-Week Study Of GW433908 And Ritonavir Or GW433908 Alone, Twice Daily In Pediatric Patients With HIV Infection
Condition: HIV Infections |
| 26. | | Completed | 506U78 in Treating Patients With Chronic Lymphocytic Leukemia That Has Not Responded to Fludarabine or Alkylating Agents
Conditions: refractory chronic lymphocytic leukemia; T-cell chronic lymphocytic leukemia; B-cell Chronic Lymphocytic Leukemia |
| 27. | | Completed | A 6 Week Study to Determine the Effectiveness of R228060 in Adult Subjects with Major Depressive Disorder
Condition: Major Depressive Disorder |
| 28. | | No longer recruiting | A 6-Month Consumer Behavior Study of a Self-Management System
Condition: Hypercholesterolemia |
| 29. | | Recruiting | A 6-week safety & efficacy study of combination intraocular pressure-lowering therapy in patients with open-angle glaucoma or ocular hypertension
Conditions: Glaucoma, Open-Angle; Ocular Hypertension |
| 30. | | Recruiting | A 6-week safety and efficacy study of Travatan compared to Xalcom in subjects with open-angle glaucoma(OAG) or ocular hypertension(OHT)
Conditions: Glaucoma, Open-Angle; Ocular Hypertension |
| 31. | | Completed | 8-Day Safety, Tolerability, and Effects Study of Inhaled INS37217 and Placebo In Adult and Pediatric Cystic Fibrosis Patients
Condition: Cystic Fibrosis |
| 32. | | Recruiting | Abciximab (ReoPro) in Acute Ischemic Stroke
Condition: Stroke |
| 33. | | No longer recruiting | ABI-007 in Taxol Resistant Patients with Metastatic Breast Cancer
Conditions: Breast Neoplasms; Metastases, Neoplasm |
| 34. | | Completed | ABT-378/Ritonavir and Efavirenz in HIV-Infected Patients Who Have Taken More Than One Protease Inhibitor in the Past
Condition: HIV Infections |
| 35. | | Completed | ABX-EGF (a monoclonal antibody) Given to Patients with Prostate Cancer with or without Tumor in Other Parts of the Body
Condition: Prostate Cancer |
| 36. | | No longer recruiting | ABX-EGF in Combination with Paclitaxel and Carboplatin for the Treatment of Advanced Non-Small-Cell Lung Cancer (NSCLC)
Conditions: Carcinoma, Non-Small-Cell Lung Neoplasm; Neoplasm Metastasis; Lung Cancer |
| 37. | | Recruiting | ABX-EGF Monotherapy in Subjects with Metastatic Colorectal Cancer
Conditions: Colorectal Cancer; Metastases |
| 38. | | Recruiting | Active Crohn’s Disease Study
Condition: Crohn Disease |
| 39. | | Completed | Active Immunization of Asymptomatic, HIV-Infected Individuals With Recombinant GP160 HIV-1 Antigen: A Phase I/II Study of Immunogenicity and Toxicity
Condition: HIV Infections |
| 40. | | Recruiting | Acute Glycemic Effects of a Very Low Fat Diet in Type 2 Diabetes
Condition: Diabetes Mellitus, Non-Insulin-Dependent |
| 41. | | Completed | Acute Myeloid Leukemia Study
Condition: Acute Myeloid Leukemia |
| 42. | | Recruiting | Acute Myeloid Leukemia Study
Condition: Acute Myeloid Leukemia |
| 43. | | Completed | AD 32 Alone or With BCG Following Surgery in Treating Patients With Newly Diagnosed or Recurrent Superficial Bladder Cancer
Conditions: stage I bladder cancer; stage 0 bladder cancer; recurrent bladder cancer |
| 44. | | Recruiting | Adalimumab for the Induction and Maintenance of Clinical Remission in Subjects with Crohn’s Disease
Condition: Crohn's Disease |
| 45. | | No longer recruiting | Addition of ISIS 14803 to Therapy with Peginterferon and Ribavirin for Chronic Hepatitis C (HCV) patients not Responding Adequately to the Two Drugs
Condition: Hepatitis C, Chronic |
| 46. | | Recruiting | Adjunct CellCept (mycophenolate mofetil) with Reduced Corticosteroids in Subjects with Myasthenia Gravis
Condition: Myasthenia Gravis |
| 47. | | No longer recruiting | Adult Outpatients with Major Depressive Disorder
Condition: Major Depressive Disorder |
| 48. | | Not yet recruiting | Adult Primary Insomnia Polysomnographic Study
Condition: Primary Insomnia |
| 49. | | Recruiting | Advanced Or Metastatic Non-Small Cell Lung Cancer Study In Patients Who Have Received One Platinum-based Chemotherapy
Condition: Non-small cell lung cancer |
| 50. | | Recruiting | Advanced Renal Cell Carcinoma
Conditions: Carcinoma, Renal Cell; Kidney Neoplasms |
